Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA minor ClinicalTrials.gov interface/version update is reflected on the page (revision v3.5.2 replaced by v3.5.3). This does not change any of the study details presented.SummaryDifference0.1%

- Check22 days agoChange DetectedA new page revision, v3.5.2, was added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check36 days agoChange DetectedThe related topics section at the bottom, including 'Prostate Cancer' and the 'MedlinePlus Genetics', was removed.SummaryDifference0.2%

- Check44 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the page. This enhances access to disease- and genetics-related information without changing the core study details.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision: v3.5.0 was added. A related topics entry for Prostate cancer: MedlinePlus Genetics was removed (including its Revision: v3.4.3).SummaryDifference0.2%

- Check58 days agoChange DetectedAdded related topics Prostate cancer and MedlinePlus Genetics, and updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.